Cibc World Markets Corp Invests $413,000 in Integer Holdings Co. (NYSE:ITGR)

Cibc World Markets Corp purchased a new position in shares of Integer Holdings Co. (NYSE:ITGR) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 3,120 shares of the medical equipment provider’s stock, valued at approximately $413,000.

Several other hedge funds also recently modified their holdings of the business. Mather Group LLC. raised its holdings in Integer by 304.3% in the 4th quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 143 shares during the period. R Squared Ltd acquired a new stake in shares of Integer in the fourth quarter valued at about $44,000. Versant Capital Management Inc increased its stake in shares of Integer by 98.4% in the fourth quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock worth $49,000 after purchasing an additional 183 shares during the period. Principal Securities Inc. lifted its position in shares of Integer by 31.2% during the 4th quarter. Principal Securities Inc. now owns 639 shares of the medical equipment provider’s stock worth $85,000 after purchasing an additional 152 shares during the last quarter. Finally, Contravisory Investment Management Inc. boosted its stake in Integer by 210.8% during the 4th quarter. Contravisory Investment Management Inc. now owns 693 shares of the medical equipment provider’s stock valued at $92,000 after purchasing an additional 470 shares during the period. Institutional investors and hedge funds own 99.29% of the company’s stock.

Integer Stock Performance

Shares of NYSE ITGR opened at $115.07 on Monday. The business has a fifty day simple moving average of $132.59 and a 200 day simple moving average of $132.38. The company has a current ratio of 2.95, a quick ratio of 2.09 and a debt-to-equity ratio of 0.62. The firm has a market capitalization of $3.87 billion, a price-to-earnings ratio of 34.25, a PEG ratio of 1.72 and a beta of 1.24. Integer Holdings Co. has a one year low of $107.11 and a one year high of $146.36.

Integer (NYSE:ITGR) last issued its earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 EPS for the quarter, missing analysts’ consensus estimates of $1.46 by ($0.03). The firm had revenue of $449.50 million during the quarter, compared to analyst estimates of $446.28 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. Sell-side analysts expect that Integer Holdings Co. will post 6.01 EPS for the current year.

Wall Street Analyst Weigh In

Several brokerages have commented on ITGR. Benchmark lifted their price target on Integer from $140.00 to $150.00 and gave the stock a “buy” rating in a research report on Friday, February 21st. KeyCorp upped their target price on shares of Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Oppenheimer lowered shares of Integer from an “outperform” rating to a “market perform” rating in a research report on Friday, February 21st. Wells Fargo & Company reaffirmed an “overweight” rating and set a $160.00 price objective on shares of Integer in a research report on Tuesday, December 3rd. Finally, Citigroup increased their target price on shares of Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a research note on Wednesday, December 11th. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $149.00.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.